We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
+3.72%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
AUM
$80.7M
AUM Growth
-$6.89M
Cap. Flow
+$3.49M
Cap. Flow %
4.33%
Top 10 Hldgs %
100%
Holding
6
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
CGON icon
CG Oncology
CGON
+$3.49M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGON icon
1
CG Oncology
CGON
$6.11B
$26.1M 32.34%
1,004,050
+145,000
+17% +$3.49M
ALMS
2
Alumis Inc
ALMS
$3.57B
$17.3M 21.48%
5,779,348
IRON icon
3
Disc Medicine
IRON
$2.83B
$15.8M 19.62%
299,069
HIMS icon
4
Hims & Hers Health
HIMS
$6.5B
$13.6M 16.87%
273,151
MAZE
5
Maze Therapeutics
MAZE
$1.53B
$4.24M 5.25%
345,191
LYEL icon
6
Lyell Immunopharma
LYEL
$309M
$3.59M 4.45%
406,652

Similar funds

Foresite Capital Management V's Q2 2025 Portfolio in Review

As of Q2 2025, Foresite Capital Management V held 6 positions worth $80.7M, down 7.9% from $87.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management V deployed $3.49M of net new capital in Q2 2025, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management V added most to CG Oncology in Q2 2025, an estimated $3.49M increase.
  • Foresite Capital Management V's ten largest holdings make up 100% of its $80.7M portfolio in Q2 2025.
  • Foresite Capital Management V opened 0 new positions and closed 0 in Q2 2025.
  • Foresite Capital Management V's portfolio value fell 7.9% quarter-over-quarter to $80.7M.

Based on Foresite Capital Management V's 13F filing for Q2 2025, filed 12 Aug 2025.